SWTX:NSD-SpringWorks Therapeutics Inc (USD)

COMMON STOCK | Biotechnology |

Last Closing

USD 42.38

Change

0.00 (0.00)%

Market Cap

USD 3.32B

Volume

0.63M

Analyst Target

USD 54.40
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-26 )

Largest Industry Peers for Biotechnology

Symbol Name Price(Change) Market Cap
VRTX Vertex Pharmaceuticals Inc

N/A

USD 124.65B
REGN Regeneron Pharmaceuticals Inc

N/A

USD 110.51B
MRNA Moderna Inc

N/A

USD 57.87B
BNTX BioNTech SE

N/A

USD 24.18B
ARGX argenx NV ADR

N/A

USD 23.04B
ALNY Alnylam Pharmaceuticals Inc

N/A

USD 20.29B
GMAB Genmab AS

N/A

USD 18.17B
BGNE BeiGene Ltd

N/A

USD 17.74B
RPRX Royalty Pharma Plc

N/A

USD 16.18B
BMRN Biomarin Pharmaceutical Inc

N/A

USD 15.32B

ETFs Containing SWTX

FLI:CA CI U.S. & Canada Lifeco C.. 9.57 % 0.92 %

N/A

CAD 0.09B
CEW:CA iShares Equal Weight Banc.. 9.36 % 0.60 %

N/A

CAD 0.19B
HEF:CA Horizons Enhanced Income .. 7.65 % 0.83 %

N/A

CAD 0.16B
HMAX:CA Hamilton Canadian Financi.. 4.59 % 0.00 %

N/A

CAD 0.78B
TQCD:CA TD Q Canadian Dividend ET.. 3.58 % 0.00 %

N/A

CAD 0.38B
TLV:CA Invesco S&P/TSX Composite.. 2.37 % 0.34 %

N/A

CAD 0.08B
XMD:CA iShares S&P/TSX Completio.. 1.80 % 0.61 %

N/A

CAD 0.24B
DXM:CA 0.00 % 0.67 %

N/A

N/A
PR:CA Lysander-Slater Preferred.. 0.00 % 1.03 %

N/A

CAD 0.08B
RODM Hartford Multifactor Deve.. 0.00 % 0.31 %

N/A

USD 1.15B
BNC:CA 0.00 % 0.68 %

N/A

N/A
XDIV:CA iShares Core MSCI Canadia.. 0.00 % 0.11 %

N/A

CAD 1.25B
CDIV:CA Manulife Smart Dividend E.. 0.00 % 0.00 %

N/A

CAD 0.50B

Market Performance

  Market Performance vs. Industry/Classification (Biotechnology) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 16.11% 69% C- 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 16.11% 69% C- 79% B-
Trailing 12 Months  
Capital Gain 52.89% 85% B 89% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 52.89% 85% B 89% A-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 24.55% 77% C+ 82% B
Dividend Return 24.55% 77% C+ 82% B
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 77.58% 36% F 21% F
Risk Adjusted Return 31.64% 84% B 66% D+
Market Capitalization 3.32B 94% A 85% B

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:
Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector